Clinical Trial Update: TMC207 +/- Rifabutin/Rifampin [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bedaquiline (TMC207) with or without rifabutin or rifampin in tuberculosis has completed. The update notes the trial's status as comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)
• RIFAMPIN (RIFAMPIN)
• bedaquiline (bedaquiline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED